Respiratory Virus Season in the U.S.: What to Know About Flu, COVID-19, and RSV Right Now
Respiratory viruses continue to circulate nationwide. Here’s what public health guidance says about symptoms, prevention, vaccines, and when to seek care.
Key takeaway: Flu, COVID-19, and RSV continue to circulate across the United States each year, especially in fall and winter. Most infections are mild, but older adults, young children, pregnant people, and those with chronic conditions face higher risk of complications. Vaccination, staying home when sick, and early treatment for high-risk individuals remain the most effective tools.
By Brian “Weence” Bateman
What’s happening
Respiratory viruses are a predictable part of the U.S. public health landscape. According to the Centers for Disease Control and Prevention (CDC), seasonal influenza, COVID-19, and respiratory syncytial virus (RSV) all surge at different points during the year, often overlapping in colder months when people spend more time indoors.
While the emergency phase of the COVID-19 pandemic has ended, the virus continues to circulate and evolve. Flu viruses shift slightly from year to year, which is why annual vaccination is recommended. RSV, once thought of mainly as a childhood illness, is now recognized as a significant cause of hospitalization in older adults as well.
Why this matters for everyday families
For most healthy people, these infections cause a week or so of fever, cough, fatigue, congestion, and body aches. But complications can include pneumonia, worsening of asthma or heart disease, dehydration, and in some cases hospitalization.
High-risk groups include:
- Adults 65 and older
- Children under 5, especially infants
- Pregnant people
- People with chronic conditions such as diabetes, lung disease, heart disease, or weakened immune systems
- Residents of long-term care facilities
When these viruses circulate widely, they can also disrupt schools, workplaces, and caregiving routines. Even mild illness can mean missed workdays and added stress for families.
Vaccines: What the evidence shows
Influenza vaccines are updated annually based on global surveillance data. The CDC recommends yearly flu vaccination for everyone 6 months and older, unless there is a specific medical reason not to receive it. Effectiveness varies from season to season, but studies consistently show reduced risk of severe illness and hospitalization.
COVID-19 vaccines are updated periodically to better match circulating variants. CDC guidance continues to recommend updated COVID-19 vaccination, particularly for older adults and people at higher risk of severe disease.
RSV vaccines and preventive products have expanded in recent years. The CDC recommends RSV vaccination for certain older adults and a preventive monoclonal antibody product for eligible infants. These recommendations are based on randomized clinical trials showing reduced risk of severe RSV disease, though long-term effectiveness and duration of protection are still being monitored.
Vaccines do not eliminate all infections, but they significantly reduce the risk of hospitalization and death — especially in higher-risk groups.
Symptoms to watch for
Many respiratory viruses look similar at first. Common symptoms include:
- Fever or chills
- Cough
- Sore throat
- Runny or stuffy nose
- Fatigue
- Muscle or body aches
- Headache
RSV in infants may cause wheezing, rapid breathing, or feeding difficulties. In older adults, RSV and flu may present primarily as worsening weakness or confusion rather than high fever.
When to seek medical care
Seek urgent medical care for:
- Trouble breathing
- Chest pain or pressure
- New confusion
- Persistent high fever
- Signs of dehydration (especially in infants or older adults)
Antiviral medications are available for influenza and COVID-19 and work best when started early — typically within the first few days of symptoms. High-risk individuals should contact a clinician promptly if they test positive or suspect infection.
Prevention still works
CDC and public health agencies continue to recommend layered prevention strategies during respiratory virus season:
- Stay up to date on recommended vaccines
- Stay home when sick
- Improve indoor ventilation when possible
- Wash hands regularly
- Consider masking in crowded indoor spaces during high transmission periods, especially if you are high risk
These measures are especially important in multi-generational households and in settings such as schools, healthcare facilities, and long-term care centers.
What remains uncertain
Respiratory viruses evolve, and timing and intensity vary year to year. Vaccine effectiveness also changes depending on how well the vaccine matches circulating strains. Public health officials monitor hospitalization rates, variant trends, and vaccine performance to adjust guidance as needed.
Researchers continue to study long COVID, long-term immunity after RSV infection, and how co-infections (having more than one virus at once) affect outcomes.
The oral-systemic connection
Respiratory infections can temporarily worsen gum inflammation and dry mouth, especially in people who are dehydrated or taking certain medications. Good oral hygiene during illness — including brushing, hydration, and replacing a toothbrush after recovery — can help reduce bacterial overgrowth and secondary infections.
What this means for readers
Respiratory virus season is now a routine part of public health planning in the United States. The practical approach is straightforward: stay current on vaccines, test when appropriate, seek early treatment if you are high risk, and use common-sense prevention steps when viruses are spreading in your community.
Most infections are manageable at home. But for higher-risk individuals, preparation and early action can make a meaningful difference.
Sources
- Centers for Disease Control and Prevention (CDC) – Seasonal Influenza Guidance
- Centers for Disease Control and Prevention (CDC) – COVID-19 Vaccination Recommendations
- Centers for Disease Control and Prevention (CDC) – RSV Information for Older Adults and Infants
- U.S. Food and Drug Administration (FDA) – Vaccine Safety and Authorization Updates
- World Health Organization (WHO) – Respiratory Virus Surveillance
This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.
This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.
